Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
Anna Waszczuk-GajdaOlaf PenackGiulia SbianchiLinda KosterDidier BlaisePéter ReményiNigel RussellQamar-Un-Nisa ChaudhryMarek TrněnýJiri MayerSimona IacobelliGuido KobbeChristof ScheidJane ApperleyCyrille TouzeauStig LenhoffEsa JantunenAchilles AnagnostopoulosLaura ParisPaul BrowneCatherine ThieblemontNicolaas SchaapJorge SierraIbrahim Yakoub AghaLaurent GarderetJan StyczyńskiHelene SchoemansIvan MoiseevRafael F DuarteZinaida PericSilvia MontotoAnja van BiezenMalgorzata MikulskaMahmoud AljurfTapani RuutuNicolaus KrögerCurly MorrisChristian KoeneckeStefan O SchönlandGrzegorz Władysław BasakPublished in: Journal of clinical medicine (2022)
Our data provide a solid basis for comparing ASCT-related complications to those caused by emerging treatments in multiple myeloma, such as CAR T-cell therapy and other immunotherapies.